Why we do not quote a flat number, and what the real cost drivers actually are once you look past the headline question.
Pharma website costs vary materially: a single-market corporate site and a twelve-language platform with an HCP portal have fundamentally different scopes of work. What actually moves the price is rarely the thing clients expect to negotiate: it is the number of markets and languages, whether a verified professional area is in scope, how deep the integration with ERP, CRM or Veeva systems goes, and — the factor most briefs leave out entirely — how many rounds of medical and legal review the content has to survive before it can go live. Understanding those drivers, rather than chasing a headline figure, is what makes one quote comparable to another at all.
A single-market corporate site for a small laboratory and a multi-market platform with an HCP portal, e-commerce and twelve languages are not the same order of project, and any number generic enough to cover both would be meaningless for either. The first might be a focused site with a handful of templates and one review cycle; the second involves distinct content governance per market, a verified professional area sitting behind its own access rules, and integration work that has nothing to do with the public-facing pages at all. Asking what a pharma website costs without specifying which of these it resembles is a bit like asking what a vehicle costs without saying whether it is a runabout or a fleet of delivery vans — the question needs narrowing before the number means anything.
Once you move past the headline figure, the same handful of variables keep showing up as the actual determinants of price. In practice, five of them do most of the work:
Adding a second market rarely means duplicating the site and swapping the copy. Each market typically carries its own regulatory nuance and its own approved claims, and sometimes its own review board, so multilingual work behaves more like a set of parallel content projects than a translation line item. The practical implication for budgeting is that pricing per market, rather than per language, gives a more honest number.
The internal review process — who has to sign off, how many rounds, how long each one takes — sits outside the build itself but shapes the timeline, and therefore the cost, of the content production phase. A project scoped without asking about this tends to under-budget the exact phase where delays are most likely to happen.
Three areas consistently land above what clients budget for going in, mostly because they are less visible in a brief than page count or design.
On an existing site with real search visibility to protect, migrating content is not a copy-paste exercise: every URL that currently ranks needs a mapped equivalent. Getting that wrong quietly costs traffic and rankings that took years to build, in a way that is hard to notice until well after launch, when it is much more expensive to fix than to have planned for.
Professional verification done properly, rather than as a checkbox, means building and maintaining a real access-control layer for the healthcare-professional area — not just a self-declaration form field. That layer has to keep working as content and roles change, which is exactly where the cost tends to sit and exactly what a checkbox implementation skips.
Supporting multiple languages superficially, with a language switcher and duplicated pages, is straightforward. Preventing content from drifting out of sync across markets over time — so a claim updated in one language does not silently stay outdated in another — requires real architecture behind the scenes, and is the difference clients notice only once it is missing.
A properly structured WordPress build, compared to an enterprise CMS licence and its associated specialist maintenance cost, often changes the total cost of ownership more than the initial build price suggests — see pharmaceutical WordPress. The saving is not only the licence fee: a well-built WordPress site can usually be maintained by your own team rather than a specialist contractor for routine changes, which is where enterprise CMS costs tend to accumulate quietly in the years after launch.
The largest cost variable is rarely visible in a brief: how many rounds of medical and legal review are assumed, whether multilingual variants are treated as near-copies or fully separate content efforts, and whether an agency has actually built for this sector before or is estimating from a generic corporate website baseline. A quote that looks unusually low relative to others has usually made an optimistic assumption about one of those three, not found a genuine efficiency. The lowest quote should be reviewed carefully against scope, assumptions and ongoing requirements.
Scope creep in this sector rarely comes from adding pages — it comes from claims and content that fail medical review late and need rework, and from multilingual variants that were scoped as simple translations but turn out to need genuine local content changes. Both are predictable and worth budgeting for explicitly rather than treated as unexpected. A contingency sized around these two specific risks tends to hold up better than a generic percentage buffer sized without knowing what it is actually for.
Scoping against your specific requirement rather than a generic estimate — see project scoping for how that discovery phase works, and how to brief a pharma web agency for what to include so the estimate you get back is actually accurate. In practice, the brief that produces a usable estimate covers:
Technical implementation is usually better left out of the brief itself and proposed by the agency against the actual requirement — specifying the solution rather than the problem often forecloses a better option.
Not usefully — a single-market corporate site with one review cycle and a multi-market platform with an HCP portal, e-commerce and twelve languages are different orders of project entirely, and a number generic enough to cover both would mislead more than help. What moves the price is the number of markets, whether a verified professional area is needed, integration depth, and how many rounds of medical and legal review the content survives before launch.
The ongoing cost of medical review time for content, since the build itself is a one-time expense while review recurs for the life of the site. Each round of sign-off shapes the content production timeline more than clients typically budget for going in, which is why scoping the review process — who signs off and how long each round takes — matters as much as scoping the pages themselves.
Usually significantly, once licence fees and ongoing specialist maintenance are counted alongside the initial build rather than compared on build cost alone. A well-built WordPress site can typically be maintained by an in-house team for routine changes, which is where enterprise CMS costs tend to accumulate quietly in the years after launch rather than in the upfront quote.
Only a rough range, since a real number needs the content volume, market count and review complexity a proper scoping conversation establishes. A brief covering the current platform, target markets and languages, and the MLR sign-off process produces an estimate worth comparing against other quotes; one that skips those specifics produces a number that cannot be meaningfully compared to anything.
Tell us your requirements and we will scope an actual estimate, not a generic figure.